Celgene (CELG) Tops Q1 EPS by 12c, Guides FY EPS In-Line

Celgene (NASDAQ: CELG) reported Q1 EPS of $2.55, $0.12 better than the analyst estimate of $2.43. Revenue for the quarter came in at $4.03 billion versus the consensus estimate of $4.01 billion.

GUIDANCE:

Celgene sees FY2019 EPS of $10.60-$10.80, versus the consensus of $10.70. Celgene sees FY2019 revenue of $17-17.2 million, versus the consensus of $17.11 million.

For earnings history and earnings-related data on Celgene (CELG) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M